Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11980614 Methods of treating RBP4 related diseases with triazolopyridines

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Cheng-Chi Irene Wang0

Yu-Hsin Tom Lin0

Konstantin Petrukhin0

Date of Patent

May 14, 2024

0

Patent Application Number

172285900

Date Filed

April 12, 2021

0

Patent Citations

US Patent 8680137 Agents and methods for treating ischemic and other diseases

0

US Patent 8980924 Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease

0

US Patent 9333202 Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease

0

US Patent 9434727 Substituted 4-phenylpiperidines, their preparation and use

0

US Patent 9487509 Heterocyclic compound

0

US Patent 9637450 Octahydrocyclopentapyrroles, their preparation and use

0

US Patent 9777010 Substituted 4-phenylpiperidines, their preparation and use

0

US Patent 9926271 Octahydrocyclopentapyrroles, their preparation and use

0

...

Patent Primary Examiner

0

CPC Code

0

Patent abstract

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11980614 Methods of treating RBP4 related diseases with triazolopyridines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool